PPT-Hanneke Schuitemaker VP, Head Viral Vaccine Discovery and Translational Medicine, Janssen

Author : debby-jeon | Published Date : 2018-11-09

Professor in Virology at the Academic Medical Center University of Amsterdam IAS Paris 24 July 2017 Evaluation of lead HIV1 vaccine regimen in APPROACH Phase

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Hanneke Schuitemaker VP, Head Viral Vacc..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Hanneke Schuitemaker VP, Head Viral Vaccine Discovery and Translational Medicine, Janssen: Transcript


Professor in Virology at the Academic Medical Center University of Amsterdam IAS Paris 24 July 2017 Evaluation of lead HIV1 vaccine regimen in APPROACH Phase 12a study testing heterologous prime boost regimens using mosaic Ad26 and MVA vectors combined with Env protein. IMMUNIZATION. . Introduction. Following an initial encounter with a pathogen, memory immune cells . are established. . . Reexposure. . to that same pathogen . reawakens these . memory cells to control the secondary infection . Revised Aug/27/20211VACCINATION PROVIDERSEMERGENCY USE AUTHORIZATION EUA OFTHE JANSSEN COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 COVID-19The US Food and Drug Administration FDA has issued a 108/20/2021 CS321571-HStanding Orders for Administering Vaccine to Persons 18 Years of Age and Older PurposeTo reduce morbidity and mortality from coronavirus disease 2019 COVID-19 by vaccinating pe 1Johnson JohnsonStanding Orders for Administering Vaccineo Persons 18 Years of Age and OlderNote For more information/guidance please contact the immunization program at your state or local health de The table below provides basic information on the proper storage preparation and administration of the currently authorized COVID-19 vaccine products in the United States For additional information an October . 2021. Coronaviruses in General. Coronavirus is a name derived from the Latin "corona," meaning crown.. The viral envelope under the electron microscope looks "crownlike" due to the small bulbar projections formed by the viral spike proteins.. Sang-Moo Kang. Georgia State University. December 8, 2015. Virology-2015 Atlanta. 1918 (H1N1) : The worst and greatest . pandemic. - deaths of 40 to 100 million people worldwide.. Lung inflammation. :. History of Vaccines. 1798: . Smallpox vaccine. 1813: . Congress creates National Vaccine Agency. 1855:. MA passes first US law mandating vaccination for schoolkids. 1896: . Cholera vaccine . 1885: . Thank you for joining us. Our program will begin at 11:30 AM Eastern.. #vaccines. #. Inlifesciences. @Marion_Health. @IUMedSchool. @darbrow. @GregoryZimet. October 27, 2020. The Importance of Vaccines. R ecombinant VACCINE  Ability to elicit the appropriate immune response for a particular pathogen.  Long term protection  Safety  Stability  inexpensiveness RECOMBINANT VACCINE  A r ��Office of Biostatistics and Epidemiology (OBE)FDA Center for Biologics Evaluation and Research (CBER ) 2 OutlineVaccine Adverse Event Reporting System (VAERS)Preliminary reports of GBS May 18, 2021. Overview. What is a vaccine? . Why we need an HIV vaccine. HIV vaccine approaches. Immune responses . What are the challenges and opportunities for HIV vaccine development?. Current HIV vaccine efficacy trials. . Amer. Virus Vaccines. First vaccine developed by Jenner in late 1700's against. smallpox virus. Vaccines. 3. 1796 Jenner: wild type animal-adapted virus. 1800’s Pasteur: Attenuated virus. . Matthew Golden, MD, MPH. Professor of Medicine, University of Washington. Director, PHSKC HIV/STD Program. Director, UW Center for AIDS and STD. COVID-19 Clinical Update. I-TECH Videoconference . February 8, 2021 .

Download Document

Here is the link to download the presentation.
"Hanneke Schuitemaker VP, Head Viral Vaccine Discovery and Translational Medicine, Janssen"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents